Home › Funds › Franklin Alternative Strategies Fund
Fund family: Franklin Alternative Strategies Funds · Filed by GEORGE PUTNAM BALANCED FUND (CIK 81259) · SEC series S000042023
Share classes and tickers: FAAAX (C000130561), FABZX (C000130565), FASCX (C000130562), FASRX (C000130564), FSKKX (C000130563)
“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 903 with, 25 against, 20 abstentions (not counted as with management); 3 items carried no recommendation. Shareholder proposals: 16 FOR, 11 AGAINST, 0 abstained, by the filing’s own vote-source field.
No item-level comparison with other Franklin Alternative Strategies Funds funds is possible: fewer than three other funds of the family voted in 2025-2026.
The same votes as “with management” above, by the sector of the company voted on. 77.6% of this fund’s 948 such votes could be given a sector; the other 212 (22.4%) are at companies without one and are not in the table.
| Sector | Votes | Against management | Share |
|---|---|---|---|
| Health Care | 312 | 10 | 3.2% |
| Utilities | 126 | 6 | 4.8% |
| Industrials | 107 | 5 | 4.7% |
| Consumer Discretionary | 56 | 3 | 5.4% |
| Technology | 44 | 0 | 0.0% |
| Finance | 32 | 0 | 0.0% |
| Miscellaneous | 22 | 0 | 0.0% |
| Consumer Staples | 17 | 1 | 5.9% |
| Basic Materials | 10 | 0 | 0.0% |
| Telecommunications | 10 | 0 | 0.0% |
| Proposal type | Items | Against management |
|---|---|---|
| Director Elections | 576 | 0 |
| Audit-related | 95 | 0 |
| Say-on-Pay | 78 | 0 |
| Compensation | 60 | 2 |
| Capital Structure | 57 | 0 |
| Corporate Governance | 54 | 12 |
| Other | 13 | 0 |
| Shareholder Rights and Defenses | 11 | 3 |
| Other Social Issues | 4 | 3 |
| Environment or Climate | 3 | 3 |
Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.
| Company | Meeting | Est. position | Items | Against mgmt |
|---|---|---|---|---|
| Kymera Therapeutics, Inc. | June 24, 2026 | $5M | 3 | 0 |
| CVS Health Corporation | May 14, 2026 | $3M | 17 | 1 |
| Edwards Lifesciences Corporation | May 7, 2026 | $3M | 12 | 0 |
| Merck & Co., Inc. | May 26, 2026 | $3M | 18 | 3 |
| Insmed Incorporated | May 13, 2026 | $2M | 3 | 0 |
| Agilent Technologies, Inc. | March 18, 2026 | $2M | 7 | 0 |
| Constellation Energy Corporation | April 28, 2026 | $2M | 14 | 1 |
| Thermo Fisher Scientific Inc. | May 20, 2026 | $2M | 13 | 0 |
| Meeting | Company | Proposal | Fund | Mgmt |
|---|---|---|---|---|
| May 14, 2026 | CVS Health Corporation | Stockholder Proposal for Reducing the Threshold for Our Stockholder Right to Act By Written Consent. Shareholder proposal | For | Against |
| May 26, 2026 | Merck & Co., Inc. | Shareholder proposal regarding a report on DEI risks in federal contracting. Shareholder proposal | Against | For |
| May 26, 2026 | Merck & Co., Inc. | Shareholder proposal regarding a report on healthcare coverage gaps. Shareholder proposal | Against | For |
| April 28, 2026 | Constellation Energy Corporation | To consider a shareholder proposal (if properly presented) requesting a report assessing the bases for the company's diversity, equity and inclusion initiatives Shareholder proposal | Against | For |
| May 4, 2026 | Eli Lilly and Company | Shareholder proposal to adopt a policy and amend the bylaws to require an independent board chair. Shareholder proposal | For | Against |
| May 4, 2026 | Eli Lilly and Company | Shareholder proposal to prepare an annual lobbying report. Shareholder proposal | Against | For |
| May 21, 2026 | NextEra Energy, Inc. | A proposal entitled "Paris Agreement Alignment" requesting NextEra Energy publish a report describing if and how the Company plans to reduce its total contribution to climate change and align its operations and investments with the Paris Agreement's goal of maintaining global temperatures well below 2 degrees Celsius, and ideally, 1.5 degrees Celsius. Shareholder proposal | For | Against |
| May 21, 2026 | NextEra Energy, Inc. | A proposal entitled "Report on Net Zero Business Performance Risks" requesting the Board of Directors of NextEra Energy prepare a report within the next year, evaluating the potential costs and benefits to NextEra Energy created by aggressive emission reduction policies. Shareholder proposal | Against | For |
| April 17, 2026 | The Boeing Company | Board Committee on Disability Access. Shareholder proposal | Against | For |
| April 17, 2026 | The Boeing Company | Action by Written Consent. Shareholder proposal | For | Against |
| May 20, 2026 | FirstEnergy Corp. | Independent Board Chairman Shareholder proposal | For | Against |
| May 13, 2026 | Vertex Pharmaceuticals Incorporated | Shareholder proposal, if properly presented at the meeting, regarding shareholder right to act by written consent. Shareholder proposal | Against | For |
955 ballot items at 97 meetings in 2025-2026. Download all votes (CSV)
Recent votes against management’s recommendation at large companies.
In the 2025-2026 proxy season, Franklin Alternative Strategies Fund (FAAAX) voted at 97 shareholder meetings of 96 companies, on 955 ballot items in all. Where management made a recommendation, the fund followed it on 95.3% of the items and voted against it 25 times. Its most frequent area of disagreement was corporate governance (12 of its votes against management). It voted on 27 shareholder proposals.
Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026. The interactive database shows the same votes company by company, with every other fund that voted.